1. Home
  2. GRNQ vs FEMY Comparison

GRNQ vs FEMY Comparison

Compare GRNQ & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$10.55

Market Cap

23.6M

Sector

Technology

ML Signal

HOLD

FEMY

Femasys Inc.

HOLD

Current Price

$2.48

Market Cap

22.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
FEMY
Founded
2013
2004
Country
Malaysia
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.6M
22.4M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
GRNQ
FEMY
Price
$10.55
$2.48
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
★ 136.3K
99.5K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ N/A
N/A
Revenue
★ $3,673,997.00
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
★ N/A
N/A
Revenue Growth
24.55
★ 40.77
52 Week Low
$1.04
$0.29
52 Week High
$22.70
$6.29

Technical Indicators

Market Signals
Indicator
GRNQ
FEMY
Relative Strength Index (RSI) 48.80 39.87
Support Level $1.51 $0.41
Resistance Level $14.40 $3.21
Average True Range (ATR) 2.38 0.19
MACD -0.52 -0.03
Stochastic Oscillator 11.89 4.51

Price Performance

Historical Comparison
GRNQ
FEMY

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China, and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust, & wealth management. Its segments include the Service business engaged in the provision of corporate advisory & business solution services; the Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong & Malaysia; & the Digital business segment engaged in the provision of digital platform & trading of digital assets.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: